-
1
المؤلفون: Jeffrey, Crawford, Jeffrey, Allen, James, Armitage, Douglas W, Blayney, Spero R, Cataland, Mark L, Heaney, Sally, Htoy, Susan, Hudock, Dwight D, Kloth, David J, Kuter, Gary H, Lyman, Brandon, McMahon, David P, Steensma, Saroj, Vadhan-Raj, Peter, Westervelt, Michael, Westmoreland
المصدر: Journal of the National Comprehensive Cancer Network. 9:914-932
مصطلحات موضوعية: Clinical Trials as Topic, Neutropenia, Fever, Cost-Benefit Analysis, Antineoplastic Agents, Risk Assessment, Anti-Bacterial Agents, Colony-Stimulating Factors, Oncology, Chemotherapy, Adjuvant, Risk Factors, Myelodysplastic Syndromes, Neoplasms, Humans, Drug Therapy, Combination
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f34ab2faafb0ee4c1d7672023690533
https://doi.org/10.6004/jnccn.2011.0075 -
2
المؤلفون: Samuel R. Denmeade, Marianna Zahurak, Roberto Pili, Daniel Keizman, Charles G. Drake, Mario A. Eisenberger, Emmanuel S. Antonarakis, Michael A. Carducci, Victoria J. Sinibaldi, Susan Hudock
المصدر: Clinical Cancer Research. 16:5269-5276
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Population, Urology, Antineoplastic Agents, Adenocarcinoma, Neutropenia, Article, Androgen deprivation therapy, Prostate cancer, Double-Blind Method, Recurrence, Biomarkers, Tumor, medicine, Humans, Testosterone, education, Lenalidomide, Aged, Aged, 80 and over, education.field_of_study, business.industry, Prostatic Neoplasms, Cancer, Middle Aged, Prostate-Specific Antigen, medicine.disease, Thalidomide, Surgery, Prostate-specific antigen, Oncology, Disease Progression, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c9d23e22aa5fd520ce9ec6b6733ce1e
https://doi.org/10.1158/1078-0432.ccr-10-1928 -
3
المؤلفون: Maria Ho, Sepideh Shayani, James Olen Armitage, Susan Hudock, David J. Kuter, Saroj Vadhan-Raj, Peter Westervelt, Ayman Saad, David P. Steensma, Hope S. Rugo, Lee S. Schwartzberg, Mahsa Talbott, Douglas W. Blayney, Jeffrey Crawford, Pamela S. Becker, Dwight D. Kloth, Spero R. Cataland, Mary A. Dwyer, Brandon McMahon, Lodovico Balducci, Gary H. Lyman, Michael Westmoreland, Mark L. Heaney
المصدر: Scopus-Elsevier
مصطلحات موضوعية: medicine.medical_specialty, Myeloid, Neutropenia, medicine.medical_treatment, Premedication, Hematopoietic stem cell transplantation, Filgrastim, Pharmacotherapy, Colony-Stimulating Factors, medicine, Humans, Chemotherapy-Induced Febrile Neutropenia, Intensive care medicine, Myelosuppressive Chemotherapy, business.industry, Hematopoietic Stem Cell Transplantation, medicine.disease, Hematopoietic Stem Cell Mobilization, medicine.anatomical_structure, Treatment Outcome, Oncology, Immunology, Chronic Disease, business, Pegfilgrastim, Febrile neutropenia, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e74190aeb99adc6cccfb6e5cf369ab9
https://pubmed.ncbi.nlm.nih.gov/24142827 -
4
المؤلفون: Tamaro Hudson, Serina King, Mario A. Eisenberger, Susan Hudock, Michael A. Carducci, Samuel R. Denmeade, Gary L. Rosner, Hans J. Hammers, Michelle A. Rudek, Emmanuel S. Antonarakis, Channing J. Paller, William D. Wagner, Xian Chong Zhou, Donna Dowling
المصدر: Journal of Clinical Oncology. 32:263-263
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Pathology, business.industry, Resveratrol, medicine.disease, Prostate cancer, chemistry.chemical_compound, Antigen, chemistry, Internal medicine, Cohort, medicine, Clinical endpoint, Doubling time, Recurrent prostate cancer, Dosing, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::21d125960ed0ce1e22a1f77cc8d43026
https://doi.org/10.1200/jco.2014.32.4_suppl.263 -
5
المؤلفون: V. J. Sinibaldi, Susan Hudock, Daniel Keizman, Samuel R. Denmeade, Charles G. Drake, Michael A. Carducci, Roberto Pili, Mario A. Eisenberger, Marianna Zahurak, Emmanuel S. Antonarakis
المصدر: Journal of Clinical Oncology. 28:4554-4554
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Double blinded, medicine.disease, Surgery, law.invention, Angiogenesis inhibitor, Prostate cancer, Phase i ii, Tolerability, Randomized controlled trial, law, Internal medicine, medicine, Immunomodulatory Agent, business, Lenalidomide, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::027b8f206c1a3ad29828ff5957c23f6f
https://doi.org/10.1200/jco.2010.28.15_suppl.4554